Travere Therapeutics
TVTX
TVTX
133 hedge funds and large institutions have $945M invested in Travere Therapeutics in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 43 increasing their positions, 49 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
12% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 49
43% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 28
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
133
Holding in Top 10
–
Calls
$2.38M
Puts
$1.26M
Top Buyers
| 1 | +$13.8M | |
| 2 | +$12.1M | |
| 3 | +$5.09M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$5.08M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.65M |
Top Sellers
| 1 | -$8.38M | |
| 2 | -$5.6M | |
| 3 | -$5.1M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$5.1M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$4.03M |